-
-
-
-
-
-
-
MorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
-
-
-
-
-
-
-
MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value
-
-
-
-
-
-
-
MorphoSys AG Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
MorphoSys AG Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
MorphoSys Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals
-
-
-
-
-
-
-
MorphoSys Reports Nine Months and Third Quarter 2020 Results
-
-
-
-
-
-
-
MorphoSys to Raise Capital via a Private Placement of New Shares
-
1,154,893 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

